Lotus Bio-Technology Development Corp. operating under the name Focal Point Healthcare, is an At-home, digital health testing corporation supporting women's health, men's health, dietary health and sexual health. The Company delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.

Employees

Sector

Healthcare Facilities & Services

More about the company

16/02/23	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
23/12/22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI

Market Cap	662K 576K 536K 492K 929K 63.21M 943K 6.32M 2.48M 31.47M 2.49M 2.43M 106M	P/E 2016	-58.1x	P/E 2017	-593x
Enterprise Value	731K 636K 592K 543K 1.03M 69.82M 1.04M 6.98M 2.74M 34.76M 2.75M 2.69M 117M	EV / Sales 2016	-	EV / Sales 2017	-
Free-Float	4.07%	Yield 2016 *	-	Yield 2017	-

16/02/23	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
23/12/22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI
14/12/22	Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding	CI
25/10/22	BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..	CI
17/08/22	Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director	CI
06/07/22	Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO	CI
06/07/22	Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.	CI
13/04/22	Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.	CI
08/04/21	Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017	CI
27/01/21	Lotus Bio-Technology Development Corp. Reports Earnings Results for the First Quarter Ended June 30, 2017	CI
11/04/19	Lotus Bio-Technology Development Corp. Announces Executive Changes	CI
22/12/18	Lotus Bio-Technology Development Corp. cancelled the acquisition of Coin Rig Solution.	CI
22/12/17	Lotus Bio-Technology Development Corp. entered into significant agreement with Coin Rig Solution.	CI

17/02/23	Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	AQ
25/10/22	Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	PR
30/08/22	Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	PR
20/08/22	Lotus Bio Technology Development : Current Report	PU
17/08/22	Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	PR

Director	Title	Age	Since
William McDonald BRD	Director/Board Member	-	24/10/2022
Michael Jay Solomon BRD	Director/Board Member	87	01/10/2022
William Graves BRD	Director/Board Member	-	-

Starflick.com Stock OTC Bulletin Board

Stocks

US85529D2036

Healthcare Facilities & Services

Valuation: Starflick.com

Latest news : Starflick.com

Press Releases: Starflick.com

Managers and Directors: Starflick.com

Other Healthcare Facilities & Services

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	-0.75%	-3.07%	+68.16%	+39.82%	133B
HCA HEALTHCARE, INC.	+1.72%	+5.34%	+13.73%	+47.57%	87.16B
FRESENIUS SE & CO. KGAA	-0.80%	+1.64%	+6.05%	+56.05%	28.85B
QUEST DIAGNOSTICS INCORPORATED	-0.55%	+2.26%	+39.19%	+72.33%	25.72B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.63%	+9.25%	-10.37%	-18.69%	21.9B
TENET HEALTHCARE CORPORATION	+0.81%	+9.25%	+57.97%	+240.93%	20.51B
DAVITA INC.	+0.51%	+1.98%	+71.04%	+135.41%	15.41B
REDE D'OR SÃO LUIZ S.A.	+0.64%	+3.77%	+6.58%	-3.78%	14.98B
FRESENIUS MEDICAL CARE AG	+0.36%	+2.73%	-0.07%	-5.87%	13.55B
Average	+0.15%	+3.27%	+28.03%	+62.64%	40.15B
Weighted average by Cap.	+0.10%	+1.72%	+37.68%	+53.73%

	2016	2017
Net sales	-	-
Net income	-781K -679K -632K -580K -1.1M -74.56M -1.11M -7.45M -2.92M -37.12M -2.93M -2.87M -124M	-19.55K -16.99K -15.82K -14.52K -27.43K -1.87M -27.85K -186K -73.18K -929K -73.42K -71.81K -3.12M
Net Debt	-5 -4.35 -4.05 -3.71 -7.01 -477.3 -7.12 -47.69 -18.72 -237.62 -18.78 -18.37 -796.79	69.21K 60.16K 56K 51.41K 97.09K 6.61M 98.59K 660K 259K 3.29M 260K 254K 11.03M